-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KvT7FMzlYEJyffXbZW4p08DJPiUu1eISIHMqso69Q5Q6Wq0XtP47lq+vBdU1TCv6 q4TcFttwgn9MDNeUiGcyiQ== 0001104659-06-041427.txt : 20060613 0001104659-06-041427.hdr.sgml : 20060613 20060613155653 ACCESSION NUMBER: 0001104659-06-041427 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060607 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20060613 DATE AS OF CHANGE: 20060613 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-31617 FILM NUMBER: 06902377 BUSINESS ADDRESS: STREET 1: 6611 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 BUSINESS PHONE: 5105052100 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 8-K 1 a06-13745_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

June 7, 2006

Date of Report (date of earliest event reported)

 

 

CIPHERGEN BIOSYSTEMS, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware

 

000-31617

 

33-059-5156

(State or other jurisdiction of

 

(Commission File Number)

 

(I.R.S. Employer

incorporation or organization)

 

 

 

Identification Number)

 

6611 Dumbarton Circle
Fremont, CA 94555

(Address of principal executive offices)

 

(510) 505-2100

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 1.01.   Entry into a Material Definitive Agreement.

On June 7, 2006, on the recommendation of the Compensation Committee of the Board of Directors (the “Board”) of Ciphergen Biosystems, Inc. (the “Company”), the Board took the following actions with respect to executive compensation. First, the Board adopted a retention bonus plan (the “Bonus Plan”) pursuant to which the following executive officers will receive a cash bonus of $50,000: James P. Merryweather, Ph.D., Executive Vice President, Sales and Marketing and William C. Sullivan, Vice President, Operations. The Bonus Plan provides that one-twelfth of the total amount of each bonus issued thereunder will vest on July 7, 2006, with the remainder vesting at a rate of one-twelfth of the total amount per month on each monthly anniversary thereafter. Unless a recipient is terminated without cause, any unvested portion of a bonus will be repayable in full to the Company should any of the aforementioned officers no longer be employed by the Company. Additionally, the Board approved an increase in the annual salary of William C. Sullivan from $197,600 to $218,000.



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CIPHERGEN BIOSYSTEMS, INC.

 

(Registrant)

 

 

 

Date: June 13, 2006

By:

/s/ GAIL S. PAGE

 

 

Gail S. Page

 

 

President and Chief Executive Officer

 


 -----END PRIVACY-ENHANCED MESSAGE-----